BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abbott IJ, Roberts JA, Meletiadis J, Peleg AY. Antimicrobial pharmacokinetics and preclinical in vitro models to support optimized treatment approaches for uncomplicated lower urinary tract infections. Expert Rev Anti Infect Ther 2021;19:271-95. [PMID: 32820686 DOI: 10.1080/14787210.2020.1813567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Abbott IJ, Peel TN, Cairns KA, Stewardson AJ. Antibiotic management of UTI in the post-antibiotic era: a narrative review highlighting diagnostic and antimicrobial stewardship. Clinical Microbiology and Infection 2022. [DOI: 10.1016/j.cmi.2022.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abbott IJ, Mouton JW, Peleg AY, Meletiadis J. Pharmacokinetic/pharmacodynamic analysis of oral fosfomycin against Enterobacterales, Pseudomonas aeruginosa and Enterococcus spp. in an in vitro bladder infection model: impact on clinical breakpoints. J Antimicrob Chemother 2021:dkab313. [PMID: 34473271 DOI: 10.1093/jac/dkab313] [Reference Citation Analysis]
3 Martinez MN, Miller RA, Martín-Jiménez T, Sharkey MJ. Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward. J Vet Pharmacol Ther 2022. [PMID: 35906854 DOI: 10.1111/jvp.13088] [Reference Citation Analysis]
4 Rodríguez-Gascón A, Solinís MÁ, Isla A. The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials. Pharmaceutics 2021;13:833. [PMID: 34205113 DOI: 10.3390/pharmaceutics13060833] [Reference Citation Analysis]